Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:59 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Paradigm Biocapital Advisors LP1,891,167
4.7%
682,116increase
(+56.42%)
View
2023-02-14
4:30 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Venrock Healthcare Capital Partners III L.P.4,230,621
9.99%
2,025,353increase
(+91.84%)
View
2023-02-14
3:05 pm
Sale
13GViridian Therapeutics, Inc.
VRDN
Cormorant Asset Management LP1,100,000
2.73%
-336,322decrease
(-23.42%)
View
2023-02-14
2:23 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
TCG Crossover GP I LLC983,610
2.4%
983,610increase
(New Position)
View
2023-02-14
11:43 am
Purchase
13GViridian Therapeutics, Inc.
VRDN
BIOTECHNOLOGY VALUE FUND L P2,302,094
5.6%
99,779increase
(+4.53%)
View
2023-02-14
08:59 am
Purchase
13GViridian Therapeutics, Inc.
VRDN
Deep Track Capital LP3,312,974
7.93%
1,493,285increase
(+82.06%)
View
2023-02-13
5:45 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Vivo Opportunity LLC1,678,207
4.2%
378,207increase
(+29.09%)
View
2023-02-09
11:35 am
Purchase
13GViridian Therapeutics, Inc.
VRDN
VANGUARD GROUP INC2,114,994
5.25%
2,114,994increase
(New Position)
View
2023-02-03
12:10 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
BlackRock Inc.
BLK
2,761,556
6.9%
2,761,556increase
(New Position)
View
2023-01-26
5:03 pm
Sale
13GViridian Therapeutics, Inc.
VRDN
MILLENNIUM MANAGEMENT LLC785,854
2%
-636,623decrease
(-44.75%)
View
2022-08-19
4:34 pm
Purchase
13DViridian Therapeutics, Inc.
VRDN
Fairmount Funds Management LLC9,192,814
19.99%
5,732,463increase
(+165.66%)
View
2022-08-12
12:35 pm
Sale
13GViridian Therapeutics, Inc.
VRDN
Frazier Life Sciences Public Fund L.P.300,000
1.1%
-1,205,200decrease
(-80.07%)
View
2022-05-31
4:40 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
MILLENNIUM MANAGEMENT LLC1,422,477
5.1%
1,422,477increase
(New Position)
View
2022-05-19
4:30 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
COMMODORE CAPITAL LP1,371,339
5%
1,371,339increase
(New Position)
View
2022-02-14
4:32 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Point72 Asset Management L.P.472,864
2.2%
46,702increase
(+10.96%)
View
2022-02-14
4:19 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Venrock Healthcare Capital Partners III L.P.2,205,268
9.99%
262,213increase
(+13.49%)
View
2022-02-14
4:11 pm
Sale
13GViridian Therapeutics, Inc.
VRDN
RA CAPITAL MANAGEMENT L.P.0
0%
-388,385decrease
(Position Closed)
View
2022-02-14
4:05 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
D. E. SHAW & CO L.P.764,613
3.5%
44,240increase
(+6.14%)
View
2022-02-14
3:04 pm
Purchase
13GViridian Therapeutics, Inc.
VRDN
Cormorant Asset Management LP1,436,322
6.28%
977,178increase
(+212.83%)
View
2022-02-14
2:47 pm
Sale
13GViridian Therapeutics, Inc.
VRDN
Logos Global Management LP0
0%
-1,495,000decrease
(Position Closed)
View
Goto 0, 1, 2, Next